
Keywords: AP-1, activator protein 1; DAMP, damage associated molecular patterns; IRAK1, interleukin-1 receptor associated kinase-1; LBP, LPS binding protein; LPS, lipopolysacharide; MAPK, mitogen-activated protein kinase; MD2, myeloid differentiation factor 2; MHC,